Novel immune checkpoint blocker approved for the treatment of advanced melanoma

Lorenzo Galluzzi; Guido Guido Kroemer; Alexander Eggermont

doi:10.4161/21624011.2014.967147

Related publications

Article2017

Trial watch: Immune checkpoint blockers for cancer therapy

Claire Vanpouille‐Box, Claire Lhuillier, Lucillia Bezu, Fernando Aranda, Takahiro Yamazaki, Oliver Kepp, Jitka Fučíková, Radek Špíšek, Sandra Demaria, Silvia C. Formenti, Laurence Zitvogel, Guido Guido Kroemer, Lorenzo Galluzzi

Article2017

Immune Checkpoint Inhibition in Hepatocellular Carcinoma: Basics and Ongoing Clinical Trials

Masatoshi Kudo

Article2014

Trial Watch

Fernando Aranda, Erika Vacchelli, Alexander Eggermont, Jérôme Galon, Wolf H. Fridman, Laurence Zitvogel, Guido Guido Kroemer, Lorenzo Galluzzi

Article2021

How we treat endocrine complications of immune checkpoint inhibitors

Stavroula Α. Paschou, Katerina Stefanaki, Θεοδώρα Ψαλτοπούλου, Michalis Liontos, Konstantinos Koutsoukos, Flora Zagouri, Ιrene Lambrinoudaki, Meletios A Dimopoulos

Article2025

Neoadjuvant triplet immune checkpoint blockade in newly diagnosed glioblastoma

Georgina V. Long, Elena Shklovskaya, Laveniya Satgunaseelan, Yizhe Mao, Inês Pires da Silva, Kristen J. Perry, Russell J. Diefenbach, Tuba N. Gide, Brindha Shivalingam, Michael E. Buckland, Maria Gonzalez, Nicole Caixeiro, Ismael A. Vergara, Xinyu Bai, Robert V. Rawson, Edward C. Hsiao, Umaimainthan Palendira, Tri Giang Phan, Alexander M. Menzies, Matteo S. Carlino, Camelia Quek, Sean M. Grimmond, Joseph H.A. Vissers, Dannel Yeo, John E.J. Rasko,